Martin Madaus

Martin Madaus

Chairman at QUANTERIX CORPORATION

Net worth: 7 M $ as of 2024-03-30

64 year
Health Technology
Commercial Services
Health Services

Profile

Martin D.
Madaus
is currently serving as the Chairman at Quanterix Corp.
since 2022 and as the Executive Chairman at Emulate, Inc. since 2020.
He is also a Director at Candela Corp., Repligen Corp., Azenta, Inc., Massachusetts High Technology Council, Inc., Unchained Labs, Ultivue, Inc., Candela Medical, Inc., Syntis Bio, Inc., Unchained Labs LLC, and Sherlock Biosciences, Inc. Additionally, Dr. Madaus has held former positions as the Chairman, President & Chief Executive Officer at EMD Millipore Corp.
from 2005 to 2010, Chairman & Chief Executive Officer at Ortho-Clinical Diagnostics, Inc. from 2014 to 2019, President & Chief Executive Officer at Roche Diagnostics Corp.
from 2000 to 2004, Chairman, President & Chief Executive Officer at Millipore SA from 2005 to 2010, and Vice President-Business Development at Roche Molecular Systems, Inc. He has also served as a Director at Pharmaceutical Product Development LLC, Mettler-Toledo International, Inc., Standard BioTools, Inc., Covidien Unlimited Co., New England Healthcare Institute, Massachusetts Technology Collaborative, Predictive Biosciences, Inc., Young Men's Christian Association of Greater Boston, Inc., and Analytical Life Science & Diagnostics Association.
Dr. Madaus holds a doctorate degree from Ludwig-Maximilians-Universität München and The University of Veterinary Medicine Hanover.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-01 276,023 ( 0.73% ) 7 M $ 2024-03-30
2024-03-17 2,308 ( 0.00% ) 424 487 $ 2024-03-30
2023-10-19 104,111 ( 0.04% ) 282 141 $ 2024-03-30
2024-02-11 2,465 ( 0.00% ) 148 590 $ 2024-03-30

Martin Madaus active positions

CompaniesPositionStart
QUANTERIX CORPORATION Chairman 2022-08-07
CANDELA MEDICAL, INC. Director/Board Member 2018-04-30
REPLIGEN CORPORATION Director/Board Member 2023-02-05
AZENTA, INC. Director/Board Member 2024-01-29
Director/Board Member -
Director/Board Member -
Director/Board Member 2021-06-30
Director/Board Member 2021-06-30
Chief Operating Officer 2020-09-08
░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of Martin Madaus

Former positions of Martin Madaus

CompaniesPositionEnd
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Martin Madaus's experience

Training of Martin Madaus

Ludwig-Maximilians-Universität München Doctorate Degree
The University of Veterinary Medicine Hanover Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Madaus's experience

Connections

99

1st degree connections

30

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
REPLIGEN CORPORATION

Health Technology

AZENTA, INC.

Health Services

METTLER-TOLEDO INTERNATIONAL, INC.

Health Technology

STANDARD BIOTOOLS INC.

Health Technology

QUANTERIX CORPORATION

Health Technology

Private companies23

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Boehringer Mannheim Corp. (California)

Analytical Life Science & Diagnostics Association

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

See company connections